Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-30

FDA Approved: ANTI DIARRHEAL — Supplemental Application (H E B)

View source ↗

Summary

FDA approved a supplemental application for an anti-diarrheal product containing loperamide HCl submitted by H E B, indicating regulatory approval of changes to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANTI DIARRHEAL (LOPERAMIDE HYDROCHLORIDE)

Snippet

SUPPL AP for ANTI DIARRHEAL (LOPERAMIDE HCL)